SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-21-004750
Filing Date
2021-11-18
Accepted
2021-11-18 07:07:49
Documents
13
Period of Report
2021-11-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acet-20211117.htm   iXBRL 8-K 58737
2 EX-99.1 acet-ex99_1.htm EX-99.1 13224
  Complete submission text file 0000950170-21-004750.txt   205795

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT acet-20211117_lab.xml EX-101.LAB 19138
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT acet-20211117_pre.xml EX-101.PRE 11504
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT acet-20211117.xsd EX-101.SCH 2495
6 EXTRACTED XBRL INSTANCE DOCUMENT acet-20211117_htm.xml XML 4877
Mailing Address 200 CLARENDON STREET FLOOR 6 BOSTON MA 02116
Business Address 200 CLARENDON STREET FLOOR 6 BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

IRS No.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38359 | Film No.: 211422591
SIC: 2834 Pharmaceutical Preparations